ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1379.xmlPalliative Care, Version 1.20142026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1379.pdf2026-04-18Palliative Care, Version 1.2014https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1396.xmlSurvivorship: Nutrition and Weight Management, Version 2.20142026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1396.pdf2026-04-18Survivorship: Nutrition and Weight Management, Version 2.2014https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1371.xmlNew Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1371.pdf2026-04-18New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxxxvi.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxxxvi.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxxxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxxxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1361.xmlBreast Cancer Risk Counseling: A Teachable Moment?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1361.pdf2026-04-18Breast Cancer Risk Counseling: A Teachable Moment?https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1359.xmlCancer Screening: When Is the Juice Worth the Squeeze?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1359.pdf2026-04-18Cancer Screening: When Is the Juice Worth the Squeeze?https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxlvii.xmlErratum2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-pxlvii.pdf2026-04-18Erratumhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1454.xmlHead and Neck Cancers, Version 2.20142026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1454.pdf2026-04-18Head and Neck Cancers, Version 2.2014https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1433.xmlPredictive Biomarkers for Anti-Epidermal Growth Factor Receptor Therapy: Beyond KRAS Testing2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1433.pdf2026-04-18Predictive Biomarkers for Anti-Epidermal Growth Factor Receptor Therapy: Beyond KRAS Testinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1443.xmlOptimizing Stem Cell Mobilization: Lessons Learned2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1443.pdf2026-04-18Optimizing Stem Cell Mobilization: Lessons Learnedhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1417.xmlCost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Asymptomatic Metastatic Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1417.pdf2026-04-18Cost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Asymptomatic Metastatic Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1409.xmlCreating An Adolescent and Young Adult Cancer Program: Lessons Learned From Pediatric and Adult Oncology Practice Bases2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1409.pdf2026-04-18Creating An Adolescent and Young Adult Cancer Program: Lessons Learned From Pediatric and Adult Oncology Practice Baseshttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1489.xmlStereotactic Body Radiation Therapy: A New Standard Option for Pancreatic Cancer?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/10/article-p1489.pdf2026-04-18Stereotactic Body Radiation Therapy: A New Standard Option for Pancreatic Cancer?https://harbor.dev.pubfactory.com/view/journals/jnccn/12/suppl_2/article-pS-1.xmlFull Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/suppl_2/article-pS-1.pdf2026-04-18Full Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic Melanoma